Raphael Mechoulam, PhD, speaks during the Marijuna Conference at the Barbizon Plaza Hotel in New York, on May 20, 1971. Known as the ‘father of cannabis research,’ Dr. Mechoulam died on March 9, 2023, ...

A retrospective chart review was conducted to identify all patients who indicated fibromyalgia as a primary reason for seeking medical cannabis and completed at least 1 follow-up visit at Harvest ...

Every year, an estimated 700,000 to 1.27 million individuals die of infection with microorganisms that have acquired resistance to antimicrobial therapy, such as methicillin-resistant Staphylococcus ...

David Meiri, PhD, was a keynote speaker at CannMed ’23 in Marco Island FL. Credit: Larry Luxner AJEM interviews Israeli cannabis researcher David Meiri, PhD, after his keynote address at CannMed '23 ...

Professor Yossi Tam, DMD, PhD, MSc, BMedSc, Director of Israel’s Multidisciplinary Center for Cannabinoid Research, has devoted his career to cannabis research. Credit: Larry Luxner. The ...

Credit: Getty Images. A medical school professor investigates why the endocannabinoid system isn't taught in American medical schools. The ECS is often described as only being in the nervous and ...

The objective of this study was to examine levels of anxiety, and depression as a comorbidity, among patients who received an authorized medical cannabis prescription from a Canadian multidisciplinary ...

Glioblastoma multiforme (GBM), also called grade IV astrocytoma, is an aggressive, malignant brain tumor with a low treatment success rate, particularly in patients with immune checkpoint-active ...

Introduction Anxiety is a natural response to real or perceived danger or threat to one’s security. The fifth edition of the Diagnostic and Statistical Manual for Mental Disorders lists disorders ...

Introduction Among the gliomas, glioblastoma multiforme (GBM; grade IV astrocytoma) is a particularly aggressive and lethal astrocytic tumor.1,2 According to the cancer stem cell (CSC) theory, ...

Credit: Getty Images. When it comes to treating chronic illness, the healthcare industry as a whole is in the process of a paradigm shift away from single molecule therapies and toward combination ...

In this episode, we talk with Yale-trained psychiatrist Jordan Sloshower, MD, MSc, about how psychedelic-assisted therapies can promote psychological flexibility, findings from his recent study on ...